Monitor for any subsequent prospectus supplement or 424B filing that would indicate an actual offering. The shelf effectiveness alone is not a trading event, but the small market cap means any future drawdown could be significantly dilutive. Traders should watch for insider selling patterns or a sudden increase in share volume as potential signals of an imminent offering.
Price Chart
Executive Summary
Galmed Pharmaceuticals' shelf registration (File No. 333-289703) was declared effective by the SEC on September 3, 2026. This allows the company to sell securities at any time, creating a potential dilution overhang for the $4M market cap micro-cap. The filing is a routine procedural step but carries material risk given the company's small size and lack of analyst bullishness (0% buy rating). The cross-filing actuarial verdict confirms an amplifier effect for IPO-context + shelf-context, but no IPO is indicated here — the shelf is the relevant context. The shelf effectiveness itself is neutral-to-bearish due to dilution risk, with no concrete offering details or pricing disclosed.
Key Facts
- Shelf registration (File No. 333-289703) declared effective on September 3, 2026.
- Company market cap is approximately $4M, making any future offering highly dilutive.
- No specific offering size, pricing, or timing disclosed in the filing.
- Analyst consensus is 0% bullish (0 Strong Buy, 0 Buy, 3 Hold, 1 Sell, 2 Strong Sell).
- Cross-filing actuarial verdict confirms amplifier effect for IPO-context + shelf-context, but no IPO is indicated.
Financial Impact
Potential dilution from future shelf takedown; no dollar amount disclosed.
Risk Factors
- Dilution risk from future shelf takedown on a $4M market cap.
- No disclosed use of proceeds or offering terms — uncertainty on timing and size.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (GLMD) — Batch item 1 | 9999999995-26-002874 |
| Document: 9999999995-26-002874-index.html | 9999999995-26-002874 |
| Document: 9999999995-26-002874.txt | 9999999995-26-002874 |
| EFFECT Filing (GLMD) — Batch item 4 | 9999999995-26-002874 |
| Document: 9999999995-26-002874-index.html | 9999999995-26-002874 |
| Document: 9999999995-26-002874.txt | 9999999995-26-002874 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 6w ago | 6-K | $4.63 $3.63 | ▼ −21.71% | ▼ −21.37% | — |
Sep 4, 2026 7w ago | EFFECT | $3.88 $4.63 | ▼ −19.33% | ▼ −20.54% | — |
Sep 3, 2026 7w ago | 6-K | $3.88 $4.63 | ▲ +19.33% | ▲ +20.54% | — |
Sep 2, 2026 7w ago | 6-K | $3.92 $4.63 | ▲ +18.11% | ▲ +19.26% | — |
Aug 19, 2026 9w ago | 6-K | $4.77 $4.33 | ▼ −9.22% | ▼ −8.84% | — |
Aug 17, 2026 10w ago | 6-K | $0.5134 | awaiting T+5 | — | — |
Jul 28, 2026 12w ago | 6-K | $0.5340 $0.5754 | ▲ +7.75% | ▲ +3.64% | — |
Jul 16, 2026 14w ago | 6-K | $0.5501 $0.5530 | ▲ +0.53% | ▲ +2.20% | — |
Jun 22, 2026 18w ago | 6-K | $0.5641 $0.5709 | ▲ +1.21% | ▲ +1.66% | — |
Jun 8, 2026 20w ago | 6-K | $0.4693 $0.6160 | ▲ +31.26% | ▲ +29.15% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers